Loading...
01/11 03:36
Loading...
Access earnings results, analyst expectations, report, slides, earnings call, and transcript.
The earnings call reveals several challenges: negative EBITDA, cash decline, project delays, and contract terminations. Although management is optimistic about future profitability and new technology, the near-term outlook is weak. The Q&A section highlights uncertainties with DOE loan guarantees, potential tariffs, and unclear management responses, further dampening sentiment. Given the negative financial performance and uncertainties, a negative stock price movement is expected in the short term.
Total Shipments Q4 2023 653 megawatts, up from guidance of 610 to 650 megawatts.
Total Shipments Q1 2024 488 megawatts, a 25% sequential decline and a 37% year-over-year decline.
Revenues Q4 2023 $229 million, roughly flat compared to the previous quarter.
Revenues Q1 2024 $187 million, 18% lower than Q4 2023.
Non-GAAP Gross Loss Q4 2023 $10 million, in-line with guidance of $5 million to $15 million.
GAAP Gross Loss Q4 2023 $34 million, due to restructuring impacts.
Non-GAAP Gross Loss Q1 2024 $13 million, a decline of nearly $3 million on a non-GAAP basis.
GAAP Gross Loss Q1 2024 $15 million, representing a sequential improvement from Q4 2023.
Total Revenues 2023 Over $1.1 billion, up 6% from 2022.
Adjusted EBITDA 2023 $4 million, compared to negative $109 million in 2022.
Net Loss Q1 2024 $186 million, compared to $108 million in the previous quarter.
Cash and Cash Equivalents Q4 2023 $197 million, down from $277 million at the end of Q3 2023.
Cash and Cash Equivalents Q1 2024 $105 million, with operating cash flows negative $73 million.
Capital Expenditures Q4 2023 $12 million, consistent with guidance.
Capital Expenditures 2023 $67 million, compared to $63 million in 2022.
Capital Expenditures Q1 2024 $19 million, a $7 million sequential increase.
Inventory Levels Q4 2023 $309 million, down from $386 million.
Inventory Levels Q1 2024 $272 million, further decreased.
Days Inventory Outstanding (DIO) Q4 2023 120 days, down from 149 days in Q3 2023.
Days Inventory Outstanding (DIO) Q1 2024 131 days.
Operating Expenses Q4 2023 $141 million, including $103 million in restructuring charges.
Non-GAAP Operating Expenses Q4 2023 $37 million, slightly better than guidance.
Operating Expenses Q1 2024 $49 million, due in part to restructuring charges.
Non-GAAP Operating Expenses Q1 2024 $39 million, similar to Q1 2023.
New Product Launch: Maxeon is progressing towards launching its first storage product, which is gaining traction with Elite dealers in Italy.
Product Transition: Maxeon is transitioning its performance line products to the latest TOPCon based version.
Market Expansion: Maxeon signed up more than 100 US Dealers since the last earnings call, focusing on those familiar with their products.
Geographic Expansion: Maxeon is making progress towards launching domestic manufacturing in Albuquerque, New Mexico.
Operational Efficiency: Maxeon initiated capacity restructuring by shutting down its cell capacity in Malaysia and retrofitting Maxeon 3 capacity in the Philippines.
Inventory Management: Efforts to work down large amounts of inventory have been slower than anticipated, impacting cash flow.
Strategic Shift: Maxeon is focusing on reducing customer concentration to increase resiliency against market volatility.
Financial Restructuring: Maxeon negotiated $97.5 million in liquidity support from TZE and restructured $200 million in convertible bonds.
Market Dislocation: Maxeon has faced significant pressure due to worldwide Chinese module oversupply, high interest rates, and policy changes.
Supply Chain Challenges: Termination of the SunPower supply agreement and delivery push outs by two primary utility scale customers have created cash flow challenges.
Cash Flow Issues: The company is experiencing serious cash flow challenges due to utility scale prepayment amortization coinciding with project delays.
Liquidity Risks: Negotiated liquidity support from TZE and restructuring of 2025 convertible bonds to address cash flow issues, leading to substantial dilution for existing shareholders.
Inventory Management: Large amounts of inventory tied up cash, with slower than anticipated efforts to reduce inventory levels.
Regulatory Risks: Potential new tariffs due to changes in US Trade Policy, including the removal of the Section 201 bifacial tariff exclusion.
Market Demand: Sluggish market demand in the US, particularly in California, and oversupply conditions in Europe affecting pricing and sales.
Project Delays: Significant project delays from large customers impacting production and cash generation capabilities.
Operational Costs: Increased product costs due to unabsorbed manufacturing overhead from curtailed production.
Dilution of Shareholder Value: Issuance of a large number of new shares due to financing transactions, resulting in substantial dilution for existing shareholders.
Liquidity Support: Maxeon negotiated commitments for significant liquidity support from its largest shareholder TZE, involving a $97.5 million debt instrument and a $100 million equity investment.
Convertible Bonds Restructuring: Restructured 2025 convertible bonds, with the majority expected to convert into equity later this year, resulting in substantial dilution for existing shareholders.
Capacity Restructuring Initiatives: Initiated capacity restructuring by shutting down Maxeon cell capacity in Malaysia and retrofitting Maxeon 3 capacity in the Philippines to enhance profitability.
Domestic Manufacturing: Progressing towards launching domestic manufacturing in Albuquerque, New Mexico.
Intellectual Property Strategy: Initiated patent infringement cases against competitors to monetize TopCon IP through licensing arrangements.
Q2 2024 Revenue Guidance: Projected revenues for Q2 2024 are expected to be between $160 million and $200 million.
2024 Annual Revenue Guidance: Projected annual revenues for 2024 are expected to be between $640 million and $800 million.
Adjusted EBITDA Guidance: Adjusted EBITDA for 2024 is expected to be in the range of negative $110 million to $160 million, with sequential improvement each quarter.
Capital Expenditures Guidance: 2024 capital expenditures are expected to be in the range of $70 million to $100 million.
Q2 2024 Capital Expenditures Guidance: Projected capital expenditures for Q2 2024 are expected to be between $15 million and $25 million.
Equity Investment from TZE: TZE has committed to an additional $100 million equity investment, which will result in their ownership of shares outstanding being at least 50.1%.
Convertible Bonds Restructuring: Substantially all holders of the $200 million 2025 convertible notes have agreed to exchange their bonds into new bonds due in 2028, convertible into equity.
Liquidity Support: TZE has agreed to invest $97.5 million into the company via a debt instrument.
The earnings call reveals several challenges: negative EBITDA, cash decline, project delays, and contract terminations. Although management is optimistic about future profitability and new technology, the near-term outlook is weak. The Q&A section highlights uncertainties with DOE loan guarantees, potential tariffs, and unclear management responses, further dampening sentiment. Given the negative financial performance and uncertainties, a negative stock price movement is expected in the short term.
All transcripts are sourced directly from the official live webcast or the company’s official investor relations website. We use the exact words spoken during the call with no paraphrasing of the core discussion.
Full verbatim transcripts are typically published within 4–12 hours after the call ends. Same-day availability is guaranteed for all S&P 500 and most mid-cap companies.
No material content is ever changed or summarized in the “Full Transcript” section. We only correct obvious spoken typos (e.g., “um”, “ah”, repeated 10 times”, or clear misspoken ticker symbols) and add speaker names/titles for readability. Every substantive sentence remains 100% as spoken.
When audio quality is poor or multiple speakers talk over each other, we mark the section instead of guessing. This ensures complete accuracy rather than introducing potential errors.
They are generated by a specialized financial-language model trained exclusively on 15+ years of earnings transcripts. The model extracts financial figures, guidance, and tone with 97%+ accuracy and is regularly validated against human analysts. The full raw transcript always remains available for verification.
